Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The mRNA for the Duffy blood group antigen, the erythrocyte receptor for the Plasmodium vivax malaria parasite, has recently been cloned and shown to encode a widely expressed chemokine receptor. Here, we show that the Duffy antigen/chemokine receptor gene (DARC) is composed of a single exon and that most Duffy-negative blacks carry a silent FY*B allele with a single T to C substitution at nucleotide -46. This mutation impairs the promoter activity in erythroid cells by disrupting a binding site for the GATA1 erythroid transcription factor. With the recent characterization of the FY*A and FY*B alleles, these findings provide the molecular basis of the Duffy blood group system and an explanation for the erythroid-specific repression of the DARC gene in Duffy-negative individuals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DARC is an atypical chemokine receptor and the antigen of the Duffy (Fy) blood group system (Tournamille et al., 1995; Tournamille et al., 1998; Wasniowska and Hadley, 1994).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Tournamille et al., 1995
In the citing paper
“A substantial part of the human population carries a homozygous mutation (FY*AES or FY*BES alleles for erythrocyte silent) in the erythroid-specific promoter of the FY gene, resulting in a lack of expression of the receptor on erythrocytes (Fya−/b− phenotype) but not in non-erythroid tissues (Tournamille et al., 1995; Zimmerman et al., 1999).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Tournamille et al., 1995
Citations
Cites
Luckow, B., & Schütz, G. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.13.5490 · Cited by 1,701
MODEL SYSTEMS FOR THE STUDY OF SEVEN-TRANSMEMBRANE-SEGMENT RECEPTORS
Dohlman, H. G., Thorner, J., Caron, M. G., & Lefkowitz, R. J. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.003253 · Cited by 1,379
The Resistance Factor to Plasmodium vivax in Blacks: The Duffy-Blood-Group Genotype,FyFy
Miller, L. H., Mason, S. J., Clyde, D. F., & McGinniss, M. H. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608052950602 · Cited by 1,260
Race, R. R., & Sanger, R. A. (1962) · Medical Entomology and Zoology · Cited by 1,162
Compilation of vertebrate-encoded transcription factors
Faisst, S., & Meyer, S. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.1.3 · Cited by 914
GATA-binding transcription factors in hematopoietic cells
Orkin, S. (1992) · Blood · doi:10.1182/blood.v80.3.575.575 · Cited by 884
Erythrocyte Receptors for ( Plasmodium Knowlesi ) Malaria: Duffy Blood Group Determinants
Miller, L. H., Mason, S. J., Dvorak, J. A., McGinniss, M. H., & Rothman, I. K. (1975) · Science · doi:10.1126/science.1145213 · Cited by 610
Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin.
Darbonne, W. C., Rice, G. C., Mohler, M. A., Apple, T., Hébert, C. A., Valente, A. J., & Baker, J. B. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115442 · Cited by 452
Globin gene regulation and switching: Circa 1990
Orkin, S. H. (1990) · Cell · doi:10.1016/0092-8674(90)90133-y · Cited by 442
Chitnis, C. E., & Miller, L. H. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.497 · Cited by 426
Research works printed but not linked: 1
- Toumamilte, C., Le Van Kim, C., Gane, P., Cartron, J.P. & Colin, Y. Molecular basis and PCR-DNA typing of the Pya/Pyb blood group polymorphism. Hum. Genet. 85, 407–410 (1995).
Cited by
Items 701–742 of 742
Transcriptional Regulation: Evolution
Wray, G. A. (2006) · Wiley eBooks · doi:10.1002/9780470015902.a0006142
Ferreira, N. S., Mathias, J. L. D. S., Albuquerque, S. R. L., de Almeida, A. C. G., Dantas, A. C., Anselmo, F. C., Lima, É. S., Lacerda, M., Nogueira, P. A., Ramasawmy, R., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-41862/v3
Ferreira, N. S., Mathias, J. L. D. S., Albuquerque, S. R. L., de Almeida, A. C. G., Dantas, A. C., Anselmo, F. C., Lima, É. S., Lacerda, M., Nogueira, P. A., Gonçalves, M. D. S., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-41862/v1
HLA and Red Blood Cell Antigen Genotyping in SARS-CoV-2 Convalescent Plasma Donors
Lemieux, W., Perreault, J., Leiva‐Torres, G. A., Baillargeon, N., Constanzo‐Yanez, J., Chevrier, M., Richard, L., Lewin, A., & Trépanier, P. (2023) · Future Virology · doi:10.2217/fvl-2022-0058
Abebe, A., Bouyssou, I., Mabilotte, S., Dugassa, S., Assefa, A., Juliano, J. J., Lo, E. Y. Y., Ménard, D., & Golassa, L. (2023) · medRxiv · doi:10.1101/2023.04.24.23289013
Mathematics and transfusion medicine.
Reverberi, R. (2007) · PubMed Central · doi:10.2450/2007.0019-07
Darc Gene Polymorphisms in Bombay Blood Group (Oh) Individuals of Indian OriginPreprint
Shaikh, R., Ghosh, K., Kashivishwanath, V., Kulkarni, S., Jadhav, S., Maru, H. D., & Gorakshakar, A. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4531363
Clinical consequences of a polygenic predisposition to benign lower white blood cell countsPreprint
Mosley, J. D., Shelley, J. P., Dickson, A. L., Zanussi, J., Daniel, L. L., Zheng, N. S., Bastarache, L. A., Wei, W., Shi, M., Jarvik, G. P., et al. (2023) · medRxiv · doi:10.1101/2023.08.20.23294331
“12 The ability of genetic variation associated with benign biomarker variation to systematically disadvantage an identifiable subset of individuals is exemplified by the rs2814778-CC genotype, which is predominantly carried by individuals of African Ancestry and underlies the clinical phenomenon of “benign neutropenia…”
BackgroundHaffener, P. E., Hopson, H. D., & Leffler, E. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.21.600103
Shao, L., Zhang, S., Nan, X., Duan, Y., & Zhou, S. (2024) · Transfusion Medicine · doi:10.1111/tme.13080
“In the Duffy blood group system, a mutation within the GATA-1 binding site of the promoter results in the Duffy-null phenotype, 3 and in the ABO blood group system, mutations such as c. – 35_ – 18del, c. (cid:2) 77C>G, c. (cid:2) 76G>C, c. (cid:2) 68G>T, and c. (cid:2) 72G>A are associated with…”
Insights into the genetic theory of infectious diseases
Moundir, A., Jeddane, L., & Bousfiha, A. A. (2024) · La Tunisie Médicale · doi:10.62438/tunismed.v102i9.4872
“This mutation prevents the expression of this receptor on the surface of erythrocytes [55].”
BackgroundMétral, S., Genetet, S., Gamain, B., & Mouro-Chanteloup, I. (2024) · Scientific Reports · doi:10.1038/s41598-024-76897-7
“…the Duffy antigen/chemokine receptor (DARC) allowing P. vivax entry into reticulocytes was analyzed, as well as proteins of the Rh complex, RhAG, RhD and RhCE carrying the Rhesus blood group antigens, as expression of these proteins is controlled by erythroid-specific transcription factors 31–36 .”
MethodTat, B., Feufack-Donfack, L. B., Yengo, B. N., Eng, V., Shenkutie, T. T., Abebe, A., Negash, M. T., Tacoli, C., Khim, N., Feleke, S. M., et al. (2025) · medRxiv · doi:10.1101/2025.09.16.25335845
“A single point mutation located in the GATA-1 transcription factor binding site of the DARC gene promoter (− 67 T>C) suppresses the expression of this receptor in erythroid cell lines, resulting in a Duffy negative phenotype [6,7].”
Identification of an in-frame insertion in ACKR1 in five individuals from Agri community, India
Roshan, S., Prakash, S., Ghosh, K., & Gorakshakar, A. (2025) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2025.106075
Góis, K. S., Braga, M., de Souza, V. H., Schavaren, J., Grava, S., Simão, A. N. C., Visentainer, J. E. L., & Neto, Q. A. D. L. (2025) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2026ao1543
Introduction to Molecular Typing
Moulds, J. M., & Sloan, S. R. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7512-6_2
“The T in the GATA sequence is altered to a C in many people of African descent and the GATA transcription factor fails to bind the site and no transcription occurs [ 7 , 8]. People with two alleles in which the GATA sequence has been replaced by GACA express no Duffy protein in RBCs and type as Fy(a−b−).”
BackgroundFerreira, N. S., Mathias, J. L. D. S., Albuquerque, S. R. L., Almeida, A. C. G., Dantas, A. C., Anselmo, F. C., Lima, E. S., Lacerda, M. V. G., Nogueira, P. A., Ramasawmy, R., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19731735
Abebe, A., Dieng, C. C., Dugassa, S., Abera, D., Shenkutie, T. T., Assefa, A., Ménard, D., Lo, E., & Golassa, L. (2024) · Figshare · doi:10.6084/m9.figshare.25282817
Ferreira, N. S., Mathias, J. L. D. S., Albuquerque, S. R. L., Almeida, A. C. G., Dantas, A. C., Anselmo, F. C., Lima, E., Lacerda, M. V. G., Nogueira, P. A., Ramasawmy, R., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19731732
Gökçebay, D. G., & Flegel, W. A. (2026) · Blood Global Hematology · doi:10.1016/j.bglo.2026.100065
“…Rh (C/c, E/e, V/VS), Kell (K/k, Js a /Js b , Kp a /Kp b ), Duffy (Fy a /Fy b , including Fy b weak and a Fy null caused by the common GATA variant 19 ), Kidd (Jk a /Jk b ), MNS (M/N, S/s, U), Lutheran (Lu a /Lu b ), Dombrock (Do a /Do b , Hy, Jo a ), Landsteiner-Wiener (LW a /LW b ), Diego (Di a…”
Evidence That GYPA (Glycophorin A) Encodes the K Blood Group System in Horses
Mackowski, M., Kajdasz, A., Laskowska, K., & Cieślak, J. (2026) · Animal Genetics · doi:10.1002/age.70083
DelaCuesta-Barrutia, J., Peñagarikano, O., Ramos-Miguel, A., & Erdozain, A. M. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111669
Negash, M. T., Baldor, L., Feufack-Donfack, L. B., Shenkutie, T. T., Khim, N., Melese, D., Abera, A., Girmachew, F., Feleke, S. M., Hailemariam, A., et al. (2026) · Malaria Journal · doi:10.1186/s12936-026-05897-x
“…Duffy-negative phenotype results from a single nucleotide mutation (67 T → C ; thymine (T) is replaced by cyto-sine (C) at 67th position) in the GATA-1 binding site of the FY gene promotor, which disrupts transcription and consequently silences DARC expression in red blood cells (RBCs) [5, 7–11].”
Roesch, C. (2020) · theses.fr (ABES) · doi:10.70675/ebb60a00z9a91z4965z9423zf7e7a2ef22ca · Cited by 1
Role of ATP2B4 and human malaria : looking for functional genetic variants associated with malaria
Nisar, S. (2020) · theses.fr (ABES) · doi:10.70675/74bb7b83zaf0dz45b5zb931z068c757b6e05
Deciphering Plasmodium vivax invasion pathway(s) in Duffy-negative patients
Bouyssou, I. (2023) · theses.fr (ABES) · doi:10.70675/c9738ea6zc314z43d9zb523z308c720f0c4e · Cited by 1
The role of admixture in the adaptation of human populations to changing environments
Cuadros-Espinoza, S. (2022) · theses.fr (ABES) · doi:10.70675/8ddb3c96z6256z4113z972fz6589a03fb4fc
Targeting the Duffy binding protein to develop a blood stage vaccine for Plasmodium vivax malaria
Martínez, F. J. M. (2023) · theses.fr (ABES) · doi:10.70675/b722e72azeb6bz49adz9eebz1a924ecb45cf
Fast pairwise coalescence enables gene-resolution scans for selection in diverse human populationsPreprint
Korfmann, K., & Mathieson, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.21.726777 · Cited by 1
Steinhaus, R., Robinson, P. N., & Seelow, D. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag449 · Cited by 1
“The ACKR1 promoter variant chr1:159204893 T > C (rs2814778) abolishes GATA1 binding and erythroid gene expression [ 47 ].”
Impact of FY*X homozygosity of the DARC receptor on Plasmodium knowlesi line A1-H.1 invasion
Díaz-Delgado, D., Meulenaere, K. D., & Rosanas‐Urgell, A. (2026) · Current Research in Parasitology and Vector-Borne Diseases · doi:10.1016/j.crpvbd.2026.100421
“The FY*B allele can carry a SNP in the GATA box in the promoter region ( (cid:0) 67T → C, previously called (cid:0) 33C → T and (cid:0) 46C → T), generating a third allele, the FY*ES ( FY*02N.01 ), which silences DARC expression in erythrocytes (Tournamille et al., 1995b).”
Altayar, M. A. (2026) · Diagnostics · doi:10.3390/diagnostics16152448
“The Fy(null) phenotype—complete absence of Duffy antigen on erythrocytes—is fixed at nearly 100% frequency in sub-Saharan African populations due to a promoter mutation (FY*O allele) that confers near-complete resistance to Plasmodium vivax malaria invasion [26,27].”
Case Report: Sickle cell anemia with complex alloimmunization
Zou, H., Alnounou, A., Kravchenko, T. R., Smeltzer, M. A., & Schaecher, C. (2026) · Frontiers in Hematology · doi:10.3389/frhem.2026.1870201
The Duffy-null phenotype in Saudi Arabia: distribution, origins and clinical significance
Madkhali, F. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.2015640
Kappler‐Gratias, S., Peyrard, T., Pennec, P. L., Cartron, J., Rouger, P., & Pham, B. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7512-6_7
“In this system, two DNA polymorphisms (FY*02M allele and FY*02N.01 allele) have been described to encode weakened or silenced expression of FY2 antigen [ 3 ,4].”
BackgroundSelf-citationAntonangelo, A. T. B. F. (2008) · Americanae (AECID Library)
Gyapong, R. N. K., & (hons, B. P. (2009) · Cited by 1
Metadata
- Authors
- Tournamille, C., Colin, Y., Cartron, J. P., & Le Van Kim, C.
- Affiliations
- Inserm (FR)
- Venue
- Nature Genetics
- Published
- 1995-06
- Volume
- 10
- Issue
- 2
- Pages
- 224-228
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2080491517
- Cited by
- 741
- References
- 32
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 23 · 2023: 28 · 2022: 20 · 2021: 28 · 2020: 27 · 2019: 23 · 2018: 22 · 2017: 27 · 2016: 21 · 2015: 22 · 2014: 25 · 2013: 33 · 2012: 25
- FWCI
- 20.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- Duffy blood group system, promoter mutations, erythroid gene expression, Plasmodium vivax, chemokine receptors, single-exon genes, African Americans
- MeSH terms
- Antigens, Protozoan, Base Sequence, Carrier Proteins, Chromosome Mapping, DNA-Binding Proteins, Duffy Blood-Group System, Erythrocytes, Genotype, Humans, Molecular Sequence Data, Mutation, Promoter Regions, Genetic, Receptors, Cell Surface, Transcription Factors, Transcription, Genetic, Tumor Cells, Cultured, Protozoan Proteins, Gene Expression, Black People, Erythroid-Specific DNA-Binding Factors, GATA1 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.